US4069819A
(en)
*
|
1973-04-13 |
1978-01-24 |
Societa Farmaceutici S.P.A. |
Inhalation device
|
US4013075A
(en)
*
|
1974-07-15 |
1977-03-22 |
I.S.F. S.P.A. |
Inhalers and insufflators having a cutting means
|
US4240418A
(en)
*
|
1974-08-22 |
1980-12-23 |
Schering Aktiengesellschaft |
Apparatus for the inhalation of medicinal agents
|
US4105027A
(en)
*
|
1975-06-13 |
1978-08-08 |
Syntex Puerto Rico, Inc. |
Inhalation device
|
US4116195A
(en)
*
|
1976-02-10 |
1978-09-26 |
Allen & Hanburys Limited |
Device for dispensing medicaments
|
US4095596A
(en)
*
|
1976-11-26 |
1978-06-20 |
Smithkline Corporation |
Nasal inhaler
|
US4338931A
(en)
*
|
1979-04-27 |
1982-07-13 |
Claudio Cavazza |
Device for the quick inhalation of drugs in powder form by humans suffering from asthma
|
US4446862A
(en)
*
|
1979-10-30 |
1984-05-08 |
Baum Eric A |
Breath actuated devices for administering powdered medicaments
|
US4889114A
(en)
*
|
1983-12-17 |
1989-12-26 |
Boehringer Ingelheim Kg |
Powdered pharmaceutical inhaler
|
US4620847A
(en)
*
|
1984-06-01 |
1986-11-04 |
Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov |
Device for administering powdered substances
|
US4645487A
(en)
*
|
1984-06-05 |
1987-02-24 |
Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov |
Device for administering powdered substances
|
US4884565A
(en)
*
|
1987-08-17 |
1989-12-05 |
Miat S.P.A. |
Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
|
AU602603B2
(en)
*
|
1987-08-17 |
1990-10-18 |
Miat S.P.A. |
Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola
|
US5152284A
(en)
*
|
1989-02-23 |
1992-10-06 |
Phidea S.P.A. |
Disposable inhaler with pre-pierced capsule
|
US6048857A
(en)
*
|
1989-10-17 |
2000-04-11 |
Ellinwood, Jr.; Everett H. |
Dosing method of administering medicaments via inhalation administration
|
US5033463A
(en)
*
|
1989-10-27 |
1991-07-23 |
Miat S.P.A. |
Multi-dose inhaler for medicaments in powder form
|
US5617845A
(en)
*
|
1990-08-30 |
1997-04-08 |
Boehringer Ingelheim Kg |
Inhalation device free from propellent gas
|
US7040549B2
(en)
|
1991-04-24 |
2006-05-09 |
Aerogen, Inc. |
Systems and methods for controlling fluid feed to an aerosol generator
|
US7628339B2
(en)
|
1991-04-24 |
2009-12-08 |
Novartis Pharma Ag |
Systems and methods for controlling fluid feed to an aerosol generator
|
US5161524A
(en)
*
|
1991-08-02 |
1992-11-10 |
Glaxo Inc. |
Dosage inhalator with air flow velocity regulating means
|
US5366122A
(en)
*
|
1991-08-27 |
1994-11-22 |
Ing. Erich Pfeiffer Gmbh & Co. Kg |
Dispenser for flowable media
|
US5460173A
(en)
*
|
1993-03-03 |
1995-10-24 |
Tenax Corporation |
Dry powder inhaler medicament carrier
|
US5388572A
(en)
*
|
1993-10-26 |
1995-02-14 |
Tenax Corporation (A Connecticut Corp.) |
Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
|
US5388573A
(en)
*
|
1993-12-02 |
1995-02-14 |
Tenax Corporation |
Dry powder inhalator medicament carrier
|
US5653191A
(en)
*
|
1994-03-01 |
1997-08-05 |
Calhoun; Clifford A. |
Pressure indicator
|
US5488946A
(en)
*
|
1994-03-01 |
1996-02-06 |
Calhoun; Clifford A. |
Emergency breathing device for opening cartridges
|
US5715811A
(en)
*
|
1994-05-26 |
1998-02-10 |
Unisia Jecs Corporation |
Inhaling type medicine administering device and using method therefor
|
WO1996012513A1
(en)
*
|
1994-10-24 |
1996-05-02 |
Oxford Biosciences Limited |
Particle delivery
|
US5901703A
(en)
*
|
1995-02-06 |
1999-05-11 |
Unisia Jecs Corporation |
Medicine administering device for nasal cavities
|
EP0761248A1
(en)
*
|
1995-03-10 |
1997-03-12 |
Unisia Jecs Corporation |
Intranasal medicator
|
US5921236A
(en)
*
|
1995-03-10 |
1999-07-13 |
Unisia Jecs Corporation |
Medicine administering device for nasal cavities
|
EP0761248A4
(en)
*
|
1995-03-10 |
1998-12-23 |
Unisia Jecs Corp |
DISTRIBUTOR FOR INTRANASANAL DRUGS
|
US7174888B2
(en)
|
1995-04-05 |
2007-02-13 |
Aerogen, Inc. |
Liquid dispensing apparatus and methods
|
US20070209659A1
(en)
*
|
1995-04-05 |
2007-09-13 |
Aerogen, Inc. |
Liquid dispensing apparatus and methods
|
US8561604B2
(en)
|
1995-04-05 |
2013-10-22 |
Novartis Ag |
Liquid dispensing apparatus and methods
|
US20040096403A1
(en)
*
|
1995-05-15 |
2004-05-20 |
Mannkind Corporation |
Method for drug delivery to the pulmonary system
|
US8394414B2
(en)
|
1995-05-15 |
2013-03-12 |
Mannkind Corporation |
Method for drug delivery to the pulmonary system
|
US5988163A
(en)
*
|
1995-08-02 |
1999-11-23 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament
|
US6209538B1
(en)
*
|
1995-08-02 |
2001-04-03 |
Robert A. Casper |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5692496A
(en)
*
|
1995-08-02 |
1997-12-02 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5823183A
(en)
*
|
1995-08-02 |
1998-10-20 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US6550477B1
(en)
|
1995-08-02 |
2003-04-22 |
Innovative Devices, Llc |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US6561186B2
(en)
|
1995-08-02 |
2003-05-13 |
Innovative Devices |
Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament
|
US5810004A
(en)
*
|
1995-10-09 |
1998-09-22 |
Unisia Jecs Corporation |
Medicator for a capsule filled with a powdered drug
|
US6013050A
(en)
*
|
1995-10-20 |
2000-01-11 |
Powderject Research Limited |
Particle delivery
|
US5752505A
(en)
*
|
1996-03-21 |
1998-05-19 |
Unisia Jecs Corporation |
Inhalation-type medicine delivery device
|
US6186141B1
(en)
*
|
1996-05-10 |
2001-02-13 |
Glaxo Wellcome Inc. |
Unit dose dispensing device
|
WO1998058695A1
(en)
*
|
1997-06-23 |
1998-12-30 |
Marco Cecchini |
Inhaling device
|
US6341605B1
(en)
*
|
1998-02-05 |
2002-01-29 |
Unisia Jecs Corporation |
Inhalant medicator
|
US6273086B1
(en)
*
|
1998-02-06 |
2001-08-14 |
Unisia Jecs Corporation |
Inhalant medicator
|
US20080230058A1
(en)
*
|
1998-06-04 |
2008-09-25 |
Nektar Therapeutics |
Dry powder dispersing apparatus and methods for their use
|
US20030209243A1
(en)
*
|
1998-06-04 |
2003-11-13 |
Inhale Therapeutic Systems |
Dry powder dispersing apparatus and methods for their use
|
US8161969B2
(en)
|
1998-06-04 |
2012-04-24 |
Novartis Ag |
Dry powder dispersing apparatus and methods for their use
|
US6546929B2
(en)
|
1998-06-04 |
2003-04-15 |
Inhale Therapeutic Systems, Inc. |
Dry powder dispersing apparatus and methods for their use
|
US6901929B2
(en)
|
1998-06-04 |
2005-06-07 |
Nektar Therapeutics |
Dry powder dispersing apparatus and methods for their use
|
US7422013B2
(en)
|
1998-06-04 |
2008-09-09 |
Nektar Therapeutics |
Dry powder dispersing apparatus and methods for their use
|
US7112341B1
(en)
|
1999-04-13 |
2006-09-26 |
Nektar Therapeutics |
Pulmonary administration of dry powder formulations for treating infertility
|
US9801925B2
(en)
|
1999-06-29 |
2017-10-31 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US20110105391A1
(en)
*
|
1999-06-29 |
2011-05-05 |
Mannkind Corporation |
Methods and Compositions for Delivering Peptides
|
US20100086609A1
(en)
*
|
1999-06-29 |
2010-04-08 |
Mannkind Corporation |
Methods and Compositions for Delivering Peptides
|
US20070020191A1
(en)
*
|
1999-06-29 |
2007-01-25 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US8889099B2
(en)
|
1999-06-29 |
2014-11-18 |
Mannkind Corporation |
Methods and compositions for delivering peptides
|
US7648960B2
(en)
|
1999-06-29 |
2010-01-19 |
Mannkind Corporation |
Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US7943178B2
(en)
|
1999-06-29 |
2011-05-17 |
Mannkind Corporation |
Methods and compositions for delivering peptides
|
US8389470B2
(en)
|
1999-06-29 |
2013-03-05 |
Mannkind Corporation |
Methods and compositions for delivering peptides
|
US20040077528A1
(en)
*
|
1999-06-29 |
2004-04-22 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US8215300B2
(en)
|
1999-07-23 |
2012-07-10 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US7464706B2
(en)
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US20080053437A1
(en)
*
|
1999-07-23 |
2008-03-06 |
Mannkind Corporation |
Unit dose capsules and dry powder inhaler
|
US9061111B2
(en)
|
1999-07-23 |
2015-06-23 |
Mannkind Corporation |
Unit dose capsules and dry powder inhaler
|
US8671937B2
(en)
|
1999-07-23 |
2014-03-18 |
Mannkind Corporation |
Unit dose capsules and dry powder inhaler
|
US8950397B2
(en)
|
1999-07-23 |
2015-02-10 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US20080190425A1
(en)
*
|
1999-07-23 |
2008-08-14 |
Steiner Solomon S |
Unit dose cartridge and dry powder inhaler
|
US20040182387A1
(en)
*
|
1999-07-23 |
2004-09-23 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
US8156936B2
(en)
|
1999-07-23 |
2012-04-17 |
Mannkind Corporation |
Unit dose capsules and dry powder inhaler
|
US20070023547A1
(en)
*
|
1999-09-09 |
2007-02-01 |
Aerogen, Inc. |
Aperture plate and methods for its construction and use
|
US8398001B2
(en)
|
1999-09-09 |
2013-03-19 |
Novartis Ag |
Aperture plate and methods for its construction and use
|
US7066398B2
(en)
|
1999-09-09 |
2006-06-27 |
Aerogen, Inc. |
Aperture plate and methods for its construction and use
|
US8501240B2
(en)
|
1999-10-29 |
2013-08-06 |
Novartis Ag |
Compositions comprising an active agent
|
US20090117193A1
(en)
*
|
1999-10-29 |
2009-05-07 |
Nektar Therapeutics |
Compositions Comprising an Active Agent
|
EP1108439A3
(de)
*
|
1999-12-15 |
2003-09-10 |
Ing. Erich Pfeiffer GmbH |
Spender für Medien
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US7331339B2
(en)
|
2000-05-05 |
2008-02-19 |
Aerogen, Inc. |
Methods and systems for operating an aerosol generator
|
US7748377B2
(en)
|
2000-05-05 |
2010-07-06 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
US7322349B2
(en)
|
2000-05-05 |
2008-01-29 |
Aerogen, Inc. |
Apparatus and methods for the delivery of medicaments to the respiratory system
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
US20020134382A1
(en)
*
|
2000-05-10 |
2002-09-26 |
Snow John M. |
Medicament container with same side airflow inlet and outlet and method of use
|
US7318436B2
(en)
|
2000-05-10 |
2008-01-15 |
Innovative Devices, Llc |
Medicament container with same side airflow inlet and outlet and method of use
|
US6948494B1
(en)
|
2000-05-10 |
2005-09-27 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet and method of use
|
US6923178B2
(en)
|
2000-05-10 |
2005-08-02 |
Innovative Devices, Llc. |
Medicament container with same side airflow inlet and outlet
|
US20050056281A1
(en)
*
|
2000-05-10 |
2005-03-17 |
Snow John M. |
Medicament container with same side airflow inlet and outlet and method of use
|
US7032593B2
(en)
|
2000-08-14 |
2006-04-25 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US7100600B2
(en)
*
|
2001-03-20 |
2006-09-05 |
Aerogen, Inc. |
Fluid filled ampoules and methods for their use in aerosolizers
|
US7195011B2
(en)
|
2001-03-20 |
2007-03-27 |
Aerogen, Inc. |
Convertible fluid feed system with comformable reservoir and methods
|
US7032590B2
(en)
|
2001-03-20 |
2006-04-25 |
Aerogen, Inc. |
Fluid filled ampoules and methods for their use in aerosolizers
|
US8196573B2
(en)
|
2001-03-20 |
2012-06-12 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
US7146978B2
(en)
|
2001-04-16 |
2006-12-12 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US7278425B2
(en)
|
2001-04-16 |
2007-10-09 |
Alkermes, Inc. |
Inhalation device and method
|
US20060283448A1
(en)
*
|
2001-04-16 |
2006-12-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US6732732B2
(en)
|
2001-04-16 |
2004-05-11 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US20040154619A1
(en)
*
|
2001-04-16 |
2004-08-12 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US20040154618A1
(en)
*
|
2001-04-16 |
2004-08-12 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US20040216738A1
(en)
*
|
2001-04-16 |
2004-11-04 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
US6978941B2
(en)
|
2001-05-02 |
2005-12-27 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
US7104463B2
(en)
|
2001-05-02 |
2006-09-12 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
US6681768B2
(en)
|
2001-06-22 |
2004-01-27 |
Sofotec Gmbh & Co. Kg |
Powder formulation disintegrating system and method for dry powder inhalers
|
US7163013B2
(en)
*
|
2001-10-05 |
2007-01-16 |
Alchemy Healthcare Limited |
Apparatus for the nasal or oral delivery of a medicament
|
US20050028813A1
(en)
*
|
2001-10-05 |
2005-02-10 |
Ian Harrison |
Apparatus for the nasal or oral delivery of a medicament
|
US7600511B2
(en)
|
2001-11-01 |
2009-10-13 |
Novartis Pharma Ag |
Apparatus and methods for delivery of medicament to a respiratory system
|
US20030150454A1
(en)
*
|
2001-11-14 |
2003-08-14 |
Inhale Therapeutic Systems, Inc. |
Aerosolization apparatus with removable mouthpiece
|
US10124128B2
(en)
*
|
2001-11-14 |
2018-11-13 |
Bgp Products Operations Gmbh |
Aerosolization apparatus with removable mouthpiece
|
US20080063606A1
(en)
*
|
2001-12-19 |
2008-03-13 |
Tarara Thomas E |
Pulmonary delivery of aminoglycoside
|
US9421166B2
(en)
|
2001-12-19 |
2016-08-23 |
Novartis Ag |
Pulmonary delivery of aminoglycoside
|
US8715623B2
(en)
|
2001-12-19 |
2014-05-06 |
Novartis Ag |
Pulmonary delivery of aminoglycoside
|
US7677467B2
(en)
|
2002-01-07 |
2010-03-16 |
Novartis Pharma Ag |
Methods and devices for aerosolizing medicament
|
US7360536B2
(en)
|
2002-01-07 |
2008-04-22 |
Aerogen, Inc. |
Devices and methods for nebulizing fluids for inhalation
|
US8539944B2
(en)
|
2002-01-07 |
2013-09-24 |
Novartis Ag |
Devices and methods for nebulizing fluids for inhalation
|
US20030131847A1
(en)
*
|
2002-01-16 |
2003-07-17 |
Fabrizio Niccolai |
Device usable in the treatment of affections of the airways
|
US6705313B2
(en)
*
|
2002-01-16 |
2004-03-16 |
Ph&T S.P.A. |
Device usable in the treatment of affections of the airways
|
US9700690B2
(en)
|
2002-03-20 |
2017-07-11 |
Mannkind Corporation |
Inhalation apparatus
|
US7353823B2
(en)
*
|
2002-05-14 |
2008-04-08 |
Bioactis Limited |
Powder chemical feeding device for nasal cavity
|
US20050177095A1
(en)
*
|
2002-05-14 |
2005-08-11 |
Tatsuo Tsutsui |
Powder chemical feeding device for nasal cavity
|
US7771642B2
(en)
|
2002-05-20 |
2010-08-10 |
Novartis Ag |
Methods of making an apparatus for providing aerosol for medical treatment
|
US20040206350A1
(en)
*
|
2002-12-19 |
2004-10-21 |
Nektar Therapeutics |
Aerosolization apparatus with non-circular aerosolization chamber
|
US9138410B2
(en)
|
2003-02-21 |
2015-09-22 |
Shin Nippon Biomedical Laboratories, Ltd. |
Compositions for nasal administration of pharmaceuticals
|
USRE45404E1
(en)
|
2003-03-27 |
2015-03-03 |
Shin Nippon Biomedical Laboratories, Ltd. |
Powder medicine applicator for nasal cavity
|
US20090260623A1
(en)
*
|
2003-04-09 |
2009-10-22 |
Novartis Pharma Ag |
Aeorosolization apparatus with air inlet shield
|
USRE47526E1
(en)
|
2003-04-09 |
2019-07-23 |
BGP Products |
Aerosolization apparatus with air inlet shield
|
US8069851B2
(en)
|
2003-04-09 |
2011-12-06 |
Novartis Ag |
Aeorosolization apparatus with air inlet shield
|
US7559325B2
(en)
|
2003-04-09 |
2009-07-14 |
Novartis Pharma Ag |
Aerosolization apparatus with air inlet shield
|
US8869794B1
(en)
*
|
2003-04-09 |
2014-10-28 |
Novartis Pharma Ag |
Aerosolization apparatus with capsule puncturing member
|
US20050150492A1
(en)
*
|
2003-04-09 |
2005-07-14 |
Nektar Therapeutics |
Aerosolization apparatus with air inlet shield
|
US8616195B2
(en)
|
2003-07-18 |
2013-12-31 |
Novartis Ag |
Nebuliser for the production of aerosolized medication
|
US20050088617A1
(en)
*
|
2003-10-27 |
2005-04-28 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
US20050153874A1
(en)
*
|
2004-01-12 |
2005-07-14 |
Mannkind Corporation |
Method of reducing serum proinsulin levels in type 2 diabetics
|
US20050186146A1
(en)
*
|
2004-02-12 |
2005-08-25 |
Nektar Therapeutics |
Interleukin-13 antagonist powders, spray-dried particles, and methods
|
US8933023B2
(en)
|
2004-03-12 |
2015-01-13 |
Biodel Inc. |
Rapid acting injectable insulin compositions
|
US20090192075A1
(en)
*
|
2004-03-12 |
2009-07-30 |
Biodel Inc. |
Amylin Formulations
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US7201167B2
(en)
|
2004-04-20 |
2007-04-10 |
Aerogen, Inc. |
Method and composition for the treatment of lung surfactant deficiency or dysfunction
|
US7946291B2
(en)
|
2004-04-20 |
2011-05-24 |
Novartis Ag |
Ventilation systems and methods employing aerosol generators
|
US7290541B2
(en)
|
2004-04-20 |
2007-11-06 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
US7267121B2
(en)
|
2004-04-20 |
2007-09-11 |
Aerogen, Inc. |
Aerosol delivery apparatus and method for pressure-assisted breathing systems
|
US20070051362A1
(en)
*
|
2004-04-23 |
2007-03-08 |
Sullivan Timothy R |
Multiple unit dose drug delivery system
|
US20050255119A1
(en)
*
|
2004-05-10 |
2005-11-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US20050250704A1
(en)
*
|
2004-05-10 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
US20050250705A1
(en)
*
|
2004-05-10 |
2005-11-10 |
Boehringer Ingelheim Pharma Gmbh Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US8664187B2
(en)
|
2004-06-18 |
2014-03-04 |
Novartis Ag |
Methods of treatment of endobronchial infections
|
US8673360B2
(en)
|
2004-08-10 |
2014-03-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Compositions that enable rapid-acting and highly absorptive intranasal administration
|
US9346766B2
(en)
|
2004-08-20 |
2016-05-24 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
US9796688B2
(en)
|
2004-08-20 |
2017-10-24 |
Mannkind Corporation |
Catalysis of diketopiperazine synthesis
|
US9675674B2
(en)
|
2004-08-23 |
2017-06-13 |
Mannkind Corporation |
Diketopiperazine salts for drug delivery and related methods
|
US10130685B2
(en)
|
2004-08-23 |
2018-11-20 |
Mannkind Corporation |
Diketopiperazine salts for drug delivery and related methods
|
US20160095989A1
(en)
*
|
2004-09-15 |
2016-04-07 |
Optinose As |
Nasal delivery devices
|
US10398859B2
(en)
*
|
2004-09-15 |
2019-09-03 |
Optinose As |
Nasal delivery devices
|
WO2006051300A1
(en)
|
2004-11-10 |
2006-05-18 |
Cipla Limited |
Inhaler
|
US8006695B2
(en)
|
2004-11-10 |
2011-08-30 |
Cipla Limited |
Inhaler
|
US20080105256A1
(en)
*
|
2004-11-10 |
2008-05-08 |
Cipla Limited |
Inhaler
|
US20110183901A1
(en)
*
|
2005-03-31 |
2011-07-28 |
Mannkind Corporation |
Superior Control of Blood Glucose in Diabetes Treatment
|
EP2594272A2
(en)
|
2005-05-18 |
2013-05-22 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US20090090433A1
(en)
*
|
2005-05-18 |
2009-04-09 |
Symyx Technologies Europe Sa |
Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts
|
US8357696B2
(en)
|
2005-05-18 |
2013-01-22 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8524735B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US10987357B2
(en)
|
2005-05-18 |
2021-04-27 |
Horizon Orphan, LLC |
Aerosolized fluoroquinolones and uses thereof
|
US8524734B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US9108211B2
(en)
|
2005-05-25 |
2015-08-18 |
Nektar Therapeutics |
Vibration systems and methods
|
US9717689B2
(en)
|
2005-09-14 |
2017-08-01 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
US10143655B2
(en)
|
2005-09-14 |
2018-12-04 |
Mannkind Corporation |
Method of drug formulation
|
US9283193B2
(en)
|
2005-09-14 |
2016-03-15 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
|
US9446001B2
(en)
|
2005-09-14 |
2016-09-20 |
Mannkind Corporation |
Increasing drug affinity for crystalline microparticle surfaces
|
US20090137455A1
(en)
*
|
2005-09-29 |
2009-05-28 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US10130581B2
(en)
|
2006-02-22 |
2018-11-20 |
Mannkind Corporation |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
US9241903B2
(en)
|
2006-02-22 |
2016-01-26 |
Mannkind Corporation |
Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
AU2007219498B2
(en)
*
|
2006-02-24 |
2013-08-22 |
Esteve, Victor |
Dry powder inhaler
|
KR101150000B1
(ko)
|
2006-02-24 |
2012-06-01 |
아하 쿤스트스트오프테크니크 게엠베하 |
건조 분말 흡입기
|
US8539946B2
(en)
|
2006-02-24 |
2013-09-24 |
Eric Zembrod |
Dry powder inhaler
|
CN101389367B
(zh)
*
|
2006-02-24 |
2011-10-05 |
阿哈塑料技术有限公司 |
干粉吸入器
|
WO2007098870A1
(de)
*
|
2006-02-24 |
2007-09-07 |
Aha Kunststofftechnik Gmbh |
Trockenpulver-inhalator
|
US20110120463A1
(en)
*
|
2006-02-24 |
2011-05-26 |
Victor Esteve |
Dry powder inhaler
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20080039368A1
(en)
*
|
2006-04-12 |
2008-02-14 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7718609B2
(en)
|
2006-04-12 |
2010-05-18 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US8584669B2
(en)
|
2006-04-13 |
2013-11-19 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
US20090194105A1
(en)
*
|
2006-04-13 |
2009-08-06 |
Jens Besseler |
Inhaler
|
US20070283955A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Bioactis Limites |
Peroral powder delivery device
|
US7806117B2
(en)
*
|
2006-06-07 |
2010-10-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Peroral powder delivery device
|
US20090320838A1
(en)
*
|
2006-06-16 |
2009-12-31 |
Cipla Limited |
Dry powder inhaler
|
US8522775B2
(en)
*
|
2006-06-16 |
2013-09-03 |
Cipla Limited |
Dry powder inhaler
|
US10195139B2
(en)
|
2006-12-26 |
2019-02-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Preparation for transnasal application
|
US8377009B2
(en)
|
2007-01-09 |
2013-02-19 |
Mystic Pharmaceuticals, Inc. |
Intranasal cartridge devices
|
US20080177246A1
(en)
*
|
2007-01-09 |
2008-07-24 |
First City Tower |
Intranasal Cartridge Devices
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
US8875704B2
(en)
|
2007-04-05 |
2014-11-04 |
Optinose As |
Nasal administration
|
US10722667B2
(en)
|
2007-04-05 |
2020-07-28 |
Optinose As |
Nasal administration
|
US20100288275A1
(en)
*
|
2007-04-05 |
2010-11-18 |
Optinose As |
Nasal administration
|
US9649456B2
(en)
*
|
2007-04-05 |
2017-05-16 |
Optinose As |
Nasal administration
|
US8683995B2
(en)
|
2007-05-16 |
2014-04-01 |
Mystic Pharmaceuticals, Inc. |
Dose dispensing containers
|
US7669597B2
(en)
|
2007-05-16 |
2010-03-02 |
Mystic Pharmaceuticals, Inc. |
Combination unit dose dispensing containers
|
US9592354B2
(en)
|
2007-05-16 |
2017-03-14 |
Mystic Pharmaceuticals, Inc. |
Combination unit dose dispensing containers
|
US9248076B2
(en)
|
2007-05-16 |
2016-02-02 |
Mystic Pharmaceuticals, Inc. |
Dose dispensing containers
|
US20090025721A1
(en)
*
|
2007-06-12 |
2009-01-29 |
Alkermes, Inc. |
Powder inhaler devices
|
US8496002B2
(en)
|
2007-06-12 |
2013-07-30 |
Civitas Therapeutics, Inc. |
Powder inhaler devices
|
US8919342B2
(en)
|
2007-08-01 |
2014-12-30 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
US20100313886A1
(en)
*
|
2007-08-01 |
2010-12-16 |
Herbert Wachtel |
Inhaler
|
CN101815552B
(zh)
*
|
2007-08-01 |
2013-03-06 |
贝林格尔.英格海姆国际有限公司 |
吸入器
|
US7963089B2
(en)
|
2007-09-14 |
2011-06-21 |
Mystic Pharmaceuticals, Inc. |
Deep draw container forming method
|
US20090071108A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Mystic Pharmaceuticals, Inc. |
Deep draw container forming method
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
US20100287884A1
(en)
*
|
2007-10-25 |
2010-11-18 |
Sangita Seshadri |
Powder conditioning of unit dose drug packages
|
US20090175840A1
(en)
*
|
2008-01-04 |
2009-07-09 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
US9125998B2
(en)
|
2008-01-24 |
2015-09-08 |
Vectura Delivery Devices Limited |
Inhaler
|
US20110056488A1
(en)
*
|
2008-01-24 |
2011-03-10 |
Vectura Delivery Devices Limited |
Inhaler
|
US10016582B2
(en)
|
2008-02-07 |
2018-07-10 |
University Of Washington Through Its Center For Commercialization |
Circumferential aerosol device
|
US20090241949A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Smutney Chad C |
Dry powder inhalation system
|
US10342938B2
(en)
|
2008-06-13 |
2019-07-09 |
Mannkind Corporation |
Dry powder drug delivery system
|
US10751488B2
(en)
|
2008-06-13 |
2020-08-25 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US9511198B2
(en)
|
2008-06-13 |
2016-12-06 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US9339615B2
(en)
|
2008-06-13 |
2016-05-17 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US10201672B2
(en)
|
2008-06-13 |
2019-02-12 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US9662461B2
(en)
|
2008-06-13 |
2017-05-30 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
US9192675B2
(en)
|
2008-06-13 |
2015-11-24 |
Mankind Corporation |
Dry powder inhaler and system for drug delivery
|
US9446133B2
(en)
|
2008-06-13 |
2016-09-20 |
Mannkind Corporation |
Dry powder inhaler and system for drug delivery
|
US10675421B2
(en)
|
2008-06-20 |
2020-06-09 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
US8623817B2
(en)
|
2008-08-11 |
2014-01-07 |
Mannkind Corporation |
Method of treating diabetes type 2 by administering ultrarapid acting insulin
|
US9943571B2
(en)
|
2008-08-11 |
2018-04-17 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US9682153B2
(en)
|
2008-09-19 |
2017-06-20 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
US20110171312A1
(en)
*
|
2008-09-19 |
2011-07-14 |
Nektar Therapeutics |
Modified therapeutic peptides, methods of their preparation and use
|
US9717738B2
(en)
|
2008-10-07 |
2017-08-01 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US10149854B2
(en)
|
2008-10-07 |
2018-12-11 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US9326936B2
(en)
|
2008-10-07 |
2016-05-03 |
Raptor Pharmaceuticals, Inc. |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US8629139B2
(en)
|
2008-10-07 |
2014-01-14 |
Mpex Pharmaceuticals, Inc. |
Topical use of Levofloxacin for reducing lung inflammation
|
US10722519B2
(en)
|
2008-10-07 |
2020-07-28 |
Horizon Orphan Llc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US8815838B2
(en)
|
2008-10-07 |
2014-08-26 |
David C. Griffith |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US11020481B2
(en)
|
2008-10-07 |
2021-06-01 |
Horizon Orphan Llc |
Topical use of levofloxacin for reducing lung inflammation
|
US10172850B2
(en)
|
2008-12-29 |
2019-01-08 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9220687B2
(en)
|
2008-12-29 |
2015-12-29 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9655850B2
(en)
|
2008-12-29 |
2017-05-23 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
US9983108B2
(en)
|
2009-03-11 |
2018-05-29 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US20110033544A1
(en)
*
|
2009-05-15 |
2011-02-10 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetcs
|
US9101539B2
(en)
|
2009-05-15 |
2015-08-11 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
US9630930B2
(en)
|
2009-06-12 |
2017-04-25 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US8827946B2
(en)
|
2009-07-31 |
2014-09-09 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
US20110045088A1
(en)
*
|
2009-07-31 |
2011-02-24 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal granisetron and nasal applicator
|
US9700564B2
(en)
|
2009-09-04 |
2017-07-11 |
Horizon Orphan Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
US10792289B2
(en)
|
2009-09-04 |
2020-10-06 |
Horizon Orphan Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
US10231975B2
(en)
|
2009-09-04 |
2019-03-19 |
Horizon Orphan Llc |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
US9706944B2
(en)
|
2009-11-03 |
2017-07-18 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
US9492625B2
(en)
|
2009-11-12 |
2016-11-15 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
EP3012258A1
(en)
|
2010-06-24 |
2016-04-27 |
Gilead Sciences, Inc. |
Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents
|
WO2011163518A1
(en)
|
2010-06-24 |
2011-12-29 |
Gilead Sciences, Inc. |
Pyrazolo [1, 5 -a] pyrimidines as antiviral agents
|
WO2012012776A1
(en)
|
2010-07-22 |
2012-01-26 |
Gilead Sciences, Inc. |
Methods and compounds for treating paramyxoviridae virus infections
|
WO2012037038A1
(en)
|
2010-09-13 |
2012-03-22 |
Gilead Sciences, Inc. |
2' -fluoro substituted carba-nucleoside analogs for antiviral treatment
|
US8651104B2
(en)
|
2010-12-07 |
2014-02-18 |
Respira Therapeutics, Inc. |
Bead-containing dry powder inhaler
|
US8561609B2
(en)
|
2010-12-07 |
2013-10-22 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
EP4059499A1
(en)
|
2011-01-31 |
2022-09-21 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
WO2012106382A1
(en)
|
2011-01-31 |
2012-08-09 |
Genoa Pharmaceuticals, Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US9550036B2
(en)
|
2011-03-03 |
2017-01-24 |
Impel Neuropharma Inc. |
Nasal drug delivery device
|
US11730903B2
(en)
|
2011-03-03 |
2023-08-22 |
Impel Pharmaceuticals Inc. |
Nasal drug delivery device
|
US10507295B2
(en)
|
2011-03-03 |
2019-12-17 |
Impel Neuropharma, Inc. |
Nasal drug delivery device
|
US10625034B2
(en)
|
2011-04-01 |
2020-04-21 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
US10940278B2
(en)
|
2011-05-09 |
2021-03-09 |
Impel Neuropharma, Inc. |
Nozzles for nasal drug delivery
|
US11890412B2
(en)
|
2011-05-09 |
2024-02-06 |
Impel Pharmaceuticals Inc. |
Nozzles for nasal drug delivery
|
US9919117B2
(en)
|
2011-05-09 |
2018-03-20 |
Impel Neuropharma Inc. |
Nozzles for nasal drug delivery
|
US11007332B2
(en)
|
2011-05-09 |
2021-05-18 |
Impel Neuropharma, Inc. |
Nozzles for nasal drug delivery
|
US9364436B2
(en)
|
2011-06-17 |
2016-06-14 |
Mannkind Corporation |
High capacity diketopiperazine microparticles and methods
|
US10130709B2
(en)
|
2011-06-17 |
2018-11-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles and methods
|
WO2013016787A1
(en)
|
2011-08-04 |
2013-02-07 |
Victor Esteve |
Powder inhaler
|
WO2013016784A1
(en)
|
2011-08-04 |
2013-02-07 |
Victor Esteve |
Dry powder inhaler
|
US10258664B2
(en)
|
2011-10-24 |
2019-04-16 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9233159B2
(en)
|
2011-10-24 |
2016-01-12 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9610351B2
(en)
|
2011-10-24 |
2017-04-04 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US11471623B2
(en)
|
2012-02-21 |
2022-10-18 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
EP3210993A1
(en)
|
2012-03-13 |
2017-08-30 |
Gilead Sciences, Inc. |
2'- substituted carba-nucleoside analogs for antiviral treatment
|
EP3932931A1
(en)
|
2012-03-13 |
2022-01-05 |
Gilead Sciences, Inc. |
A nebulizer comprising a pharmaceutical composition comprising 2'- substituted carba-nucleoside analogs for antiviral treatment
|
MD4496C1
(ro)
*
|
2012-03-13 |
2018-02-28 |
Gilead Sciences, Inc. |
Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral
|
EP3351552A1
(en)
|
2012-03-13 |
2018-07-25 |
Gilead Sciences, Inc. |
2'- substituted carba-nucleoside analogs for antiviral treatment
|
WO2013158776A1
(en)
|
2012-04-17 |
2013-10-24 |
Gilead Sciences, Inc. |
Compounds and methods for antiviral treatment
|
US20130327327A1
(en)
*
|
2012-06-06 |
2013-12-12 |
Aerodesigns, Inc. |
Aerosol dispenser with replaceable cartridge
|
US9845187B2
(en)
*
|
2012-06-06 |
2017-12-19 |
Aerodesigns, Inc. |
Aerosol dispenser with replaceable cartridge
|
US10441733B2
(en)
|
2012-06-25 |
2019-10-15 |
Respira Therapeutics, Inc. |
Powder dispersion devices and methods
|
US9802012B2
(en)
|
2012-07-12 |
2017-10-31 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
US9757529B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US9757395B2
(en)
|
2012-12-20 |
2017-09-12 |
Otitopic Inc. |
Dry powder inhaler and methods of use
|
US10421729B2
(en)
|
2013-03-15 |
2019-09-24 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
US10537692B2
(en)
|
2013-04-28 |
2020-01-21 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
US11191910B2
(en)
|
2013-04-28 |
2021-12-07 |
Impel Neuropharma, Inc. |
Medical unit dose container
|
US11865210B2
(en)
|
2013-04-30 |
2024-01-09 |
Vectura Inc. |
Dry powder formulations and methods of use
|
US10149823B2
(en)
|
2013-04-30 |
2018-12-11 |
Otitopic Inc. |
Dry powder formulations and methods of use
|
US11819569B2
(en)
|
2013-04-30 |
2023-11-21 |
Vectura Inc. |
Treating inflammation with inhaled aspirin
|
US10207065B2
(en)
|
2013-07-12 |
2019-02-19 |
John H. Silva |
Mouthpiece for inhalers
|
WO2015006838A1
(en)
|
2013-07-16 |
2015-01-22 |
Victor Esteve |
Powder inhaler
|
US9925144B2
(en)
|
2013-07-18 |
2018-03-27 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
EP3782604A1
(en)
|
2013-07-31 |
2021-02-24 |
Windward Pharma, Inc. |
Aerosol tyrosine kinase inhibitor compounds and uses thereof
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
EP3505173A1
(en)
|
2013-11-11 |
2019-07-03 |
Gilead Sciences, Inc. |
Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
|
EP4122932A1
(en)
|
2013-11-11 |
2023-01-25 |
Gilead Sciences, Inc. |
Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
|
US10028966B2
(en)
|
2014-01-10 |
2018-07-24 |
Avalyn Pharma Inc. |
Aerosol pirfenidone and pyridone analog compounds and uses thereof
|
US9993488B2
(en)
|
2014-02-20 |
2018-06-12 |
Otitopic Inc. |
Dry powder formulations for inhalation
|
USD755367S1
(en)
|
2014-03-10 |
2016-05-03 |
Civitas Therapeutics, Inc. |
Indicator for an inhaler
|
USD752734S1
(en)
|
2014-03-10 |
2016-03-29 |
Civitas Therapeutics, Inc. |
Inhaler grip
|
USD752204S1
(en)
|
2014-03-10 |
2016-03-22 |
Civitas Therapeutics, Inc. |
Indicator for an inhaler
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
USD748242S1
(en)
|
2014-07-11 |
2016-01-26 |
H. Stuart Campbell |
Inhaler mouthpiece
|
WO2016018697A1
(en)
|
2014-07-28 |
2016-02-04 |
Gilead Sciences, Inc. |
Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections
|
EP4023650A1
(en)
|
2014-07-28 |
2022-07-06 |
Gilead Sciences, Inc. |
4'-substituted-furo[3,2-d]pyrimidine and -pyrrolo[3,2- d]pyrimidine derivatives useful for treating respiratory syncitial virus infections
|
EP3693367A1
(en)
|
2014-07-28 |
2020-08-12 |
Gilead Sciences, Inc. |
Thieno [3,2-d]pyrimidines, furo [3,2,d]pyrimidines and pyrrolo [3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
|
EP3738969A1
(en)
|
2014-08-21 |
2020-11-18 |
Gilead Sciences, Inc. |
2'-chloro aminopyrimidinone and pyrimidine dione nucleosides for use in treating pneumovirinae virus infections
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US10874139B2
(en)
*
|
2015-07-07 |
2020-12-29 |
Altria Client Services Llc |
E-vapor device including capsule containing pre-vapor formulation
|
US20170006917A1
(en)
*
|
2015-07-07 |
2017-01-12 |
Altria Client Services Inc. |
E-vapor device including capsule containing pre-vapor formulation
|
US11266799B2
(en)
|
2015-09-10 |
2022-03-08 |
Impel Neuropharma, Inc. |
In-line nasal delivery device
|
WO2017094027A1
(en)
*
|
2015-12-01 |
2017-06-08 |
Cipla Limited |
Nasal spray assembly
|
US10940274B2
(en)
|
2015-12-01 |
2021-03-09 |
Cipla Limited |
Nasal spray assembly
|
US11273268B2
(en)
*
|
2016-07-07 |
2022-03-15 |
Philip Morris Products S.A. |
Nicotine inhaler system
|
US12102754B2
(en)
|
2017-09-26 |
2024-10-01 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
US11744967B2
(en)
|
2017-09-26 |
2023-09-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
US11672926B2
(en)
*
|
2017-10-12 |
2023-06-13 |
Aptar France Sas |
Device for dispensing a fluid product
|
US20200289769A1
(en)
*
|
2017-10-12 |
2020-09-17 |
Aptar France Sas |
Device for dispensing a fluid product
|
CN111372635B
(zh)
*
|
2017-11-21 |
2022-08-16 |
英倍尔制药公司 |
带有入口接口的鼻内装置
|
US11878110B2
(en)
|
2017-11-21 |
2024-01-23 |
Impel Pharmaceuticals Inc. |
Intranasal device with inlet interface
|
US11571532B2
(en)
|
2017-11-21 |
2023-02-07 |
Impel Pharmaceuticals Inc. |
Intranasal device with dip tube
|
US11395887B2
(en)
|
2017-11-21 |
2022-07-26 |
Impel Pharmaceuticals Inc. |
Intranasal device with inlet interface
|
CN111372635A
(zh)
*
|
2017-11-21 |
2020-07-03 |
英倍尔药业股份有限公司 |
带有入口接口的鼻内装置
|
US11185497B2
(en)
|
2018-01-05 |
2021-11-30 |
Impel Neuropharma, Inc. |
Intranasal delivery of dihydroergotamine by precision olfactory device
|
US11752100B2
(en)
|
2018-01-05 |
2023-09-12 |
Impel Pharmaceuticals Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
US11278492B2
(en)
|
2018-01-05 |
2022-03-22 |
Impel Neuropharma, Inc. |
Intranasal delivery of olanzapine by precision olfactory device
|
US11517548B2
(en)
|
2018-07-19 |
2022-12-06 |
Impel Pharmaceuticals Inc. |
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
|
US11690819B2
(en)
|
2018-07-19 |
2023-07-04 |
Impel Pharmaceuticals Inc. |
Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease
|
CN109078245A
(zh)
*
|
2018-10-11 |
2018-12-25 |
上海博极给药医药科技有限公司 |
一种双胶囊型干粉吸入装置
|
US11759585B2
(en)
|
2019-01-03 |
2023-09-19 |
Impel Pharmaceuticals Inc. |
Nasal drug delivery device with detachable nozzle
|
US11878109B2
(en)
|
2019-05-17 |
2024-01-23 |
Impel Pharmaceuticals Inc. |
Single-use nasal delivery device
|
WO2021130638A1
(en)
|
2019-12-24 |
2021-07-01 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
EP4445902A2
(en)
|
2019-12-24 |
2024-10-16 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
WO2021168004A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2021168038A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2021168008A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
A 5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2-cyano-3,4-dihydroxytetrahydrofurane derivative as antiviral agent
|
WO2021167882A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
WO2021222522A1
(en)
|
2020-05-01 |
2021-11-04 |
Gilead Sciences, Inc. |
Cd73 inhibiting 2,4-dioxopyrimidine compounds
|
WO2022240897A1
(en)
|
2021-05-10 |
2022-11-17 |
Sepelo Therapeutics, Llc |
Pharmaceutical composition comprising delafloxacin for administration into the lung
|
WO2022271650A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2022271684A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2022271659A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2022271677A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
WO2023028364A1
(en)
|
2021-08-27 |
2023-03-02 |
Sepelo Therapeutics, Llc |
Targeted compositions and uses therof
|
WO2023077030A1
(en)
|
2021-10-29 |
2023-05-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|